Combined Serum Expression of lncRNA CBR3‐AS1 and miR‐3163: Prognostic Significance and Underlying Mechanism in Severe Pneumonia
The Clinical Respiratory Journal · 2026-07 · 20 (7)
DOI: 10.1111/crj.70206 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 07.07.2026. Verfasst von Chao Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Pneumonia. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Severe pneumonia (SP) is a life‐threatening pulmonary infection characterized by high morbidity, frequent complications, and elevated mortality, with rising global incidence in recent years. This study investigated the prognostic value and molecular mechanisms of lncRNA CBR3‐AS1 (CBR3‐AS1) in patients with SP.
Methods
CBR3‐AS1 and miR‐3163 levels were evaluated by real‐time quantitative polymerase chain reaction (RT‐qPCR). The targeting relationship was confirmed by bioinformatics prediction, dual‐luciferase activity assay, and RNA immunoprecipitation (RIP) assay. Cell viability and related indicators were detected by cell counting kit‐8 (CCK‐8), flow cytometry, and enzyme‐linked immunosorbent assay (ELISA).
Results
Serum analysis revealed markedly upregulated CBR3‐AS1 and downregulated miR‐3163 in SP patients versus healthy controls (HC), with bioinformatic and experimental evidence confirming their targeting relationship. In addition, CBR3‐AS1 and miR‐3163 were influential factors affecting death in SP patients and were sensitive predictors of poor patient prognosis. Mechanistically, silencing CBR3‐AS1 promoted the proliferation of MRC‐5 cells after LPS induction, although the miR‐3163 inhibitor partially abolished these changes. Similarly, oxidative stress and inflammatory markers in MRC‐5 cells were also regulated by CBR3‐AS1 and miR‐3163.
Conclusions
CBR3‐AS1 sponge miR‐3163 mediates MRC‐5 cell viability, oxidative stress, and inflammation levels, which ultimately affects the progression of SP. CBR3‐AS1/miR‐3163 axis represents a promising therapeutic target for improving SP patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, The Affiliated Hospital of Southwest Medical University, Sichuan, China.
- Department of Respiratory and Critical Care Medicine, People's Hospital of Fengjie, Fengjie, China.
- Department of Respiratory and Critical Care Medicine, the Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.
- Department of ICU, Shanghai Songjiang Sijing Hospital, Shanghai, China.
ORCID-Profile: Pan Long
Zitieren
APA
Liu, C., Li, M., Yang, J., & Long, P. (2026). Combined Serum Expression of lncRNA CBR3‐AS1 and miR‐3163: Prognostic Significance and Underlying Mechanism in Severe Pneumonia. The Clinical Respiratory Journal, 20(7). https://doi.org/10.1111/crj.70206
Vancouver
Liu C, Li M, Yang J, Long P. Combined Serum Expression of lncRNA CBR3‐AS1 and miR‐3163: Prognostic Significance and Underlying Mechanism in Severe Pneumonia. The Clinical Respiratory Journal. 2026;20(7). doi:10.1111/crj.70206
BibTeX
@article{Liu2026,
author = {Liu, Chao and Li, Meie and Yang, Junfa and Long, Pan},
title = {Combined Serum Expression of lncRNA CBR3‐AS1 and miR‐3163: Prognostic Significance and Underlying Mechanism in Severe Pneumonia},
journal = {The Clinical Respiratory Journal},
year = {2026},
volume = {20},
number = {7},
doi = {10.1111/crj.70206}
}
EUVIMED